{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:08:44Z","timestamp":1790755724613,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019959","name":"Inozyme Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bone.2023.116750","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T19:30:25Z","timestamp":1680204625000},"page":"116750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Effects of food, fasting, and exercise on plasma pyrophosphate levels and ENPP1 activity in healthy adults"],"prefix":"10.1016","volume":"171","author":[{"given":"Gus","family":"Khursigara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Wenkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2023.116750_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4439(03)00058-9","article-title":"Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase\/phosphodiesterase family","volume":"1638","author":"Goding","year":"2003","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"6","key":"10.1016\/j.bone.2023.116750_bb0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.7150\/ijbs.4538","article-title":"Phosphate\/pyrophosphate and MV-related proteins in mineralisation: discoveries from mouse models","volume":"8","author":"Zhou","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bone.2023.116750_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2016.03.003","article-title":"Pyrophosphate: a key inhibitor of mineralisation","volume":"28","author":"Orriss","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bone.2023.116750_bb0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11914-017-0370-3","article-title":"Inherited arterial calcification syndromes: etiologies and treatment concepts","volume":"15","author":"Nitschke","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"24","key":"10.1016\/j.bone.2023.116750_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413536","article-title":"Vascular calcification: key roles of phosphate and pyrophosphate","volume":"22","author":"Villa-Bellosta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bone.2023.116750_bb0030","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.2001.281.1.C1","article-title":"Inorganic pyrophosphate generation and disposition in pathophysiology","volume":"281","author":"Terkeltaub","year":"2001","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.bone.2023.116750_bb0035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bone.2012.07.014","article-title":"New insights into NPP1 function: lessons from clinical and animal studies","volume":"51","author":"Mackenzie","year":"2012","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2023.116750_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032177","article-title":"Altered bone development and an increase in FGF-23 expression in Enpp1(-\/-) mice","volume":"7","author":"Mackenzie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2023.116750_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115243","article-title":"Extracellular pyrophosphate: the body's \"water softener\"","volume":"134","author":"Orriss","year":"2020","journal-title":"Bone"},{"issue":"50","key":"10.1016\/j.bone.2023.116750_bb0050","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1073\/pnas.1319582110","article-title":"ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release","volume":"110","author":"Jansen","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bone.2023.116750_bb0055","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/jbmr.3911","article-title":"Human heterozygous ENPP1 deficiency is associated with early onset osteoporosis, a phenotype recapitulated in a mouse model of Enpp1 deficiency","volume":"35","author":"Oheim","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2023.116750_bb0060","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.jid.2017.06.006","article-title":"Plasma PPi deficiency is the major, but not the exclusive, cause of ectopic mineralization in an Abcc6(-\/-) mouse model of PXE","volume":"137","author":"Zhao","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.bone.2023.116750_bb0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jbmr.4528","article-title":"The mineralization regulator ANKH mediates cellular efflux of ATP, not pyrophosphate","volume":"37","author":"Szeri","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.bone.2023.116750_bb0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bone.2011.06.029","article-title":"A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene","volume":"49","author":"Saito","year":"2011","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2023.116750_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/CIRCGENETICS.108.797704","article-title":"Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy","volume":"1","author":"Boyer","year":"2008","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"10.1016\/j.bone.2023.116750_bb0080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","article-title":"Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene","volume":"86","author":"Levy-Litan","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.bone.2023.116750_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","article-title":"Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets","volume":"86","author":"Lorenz-Depiereux","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bone.2023.116750_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115656","article-title":"Genetic pathways disrupted by ENPP1 deficiency provide insight into mechanisms of osteoporosis, osteomalacia, and paradoxical mineralization","volume":"142","author":"Maulding","year":"2021","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2023.116750_bb0095","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jbmr.4487","article-title":"Musculoskeletal comorbidities and quality of life in ENPP1-deficient adults and the response of enthesopathy to enzyme replacement therapy in murine models","volume":"37","author":"Ferreira","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2023.116750_bb0100","article-title":"Lifelong impact of ENPP1 deficiency and the early onset form of ABCC6 deficiency from patient or caregiver perspective","volume":"17","author":"O'Brien","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bone.2023.116750_bb0105","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/rheumatology\/kes089","article-title":"Novel compound heterozygous mutations in ENPP1 cause hypophosphataemic rickets with anterior spinal ligament ossification","volume":"51","author":"Mehta","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.bone.2023.116750_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tcm.2012.07.011","article-title":"Genetics in arterial calcification: lessons learned from rare diseases","volume":"22","author":"Nitschke","year":"2012","journal-title":"Trends Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.bone.2023.116750_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajhg.2011.11.020","article-title":"Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6","volume":"90","author":"Nitschke","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.bone.2023.116750_bb0120","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","article-title":"Alkaline phosphatase and hypophosphatasia","volume":"98","author":"Millan","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bone.2023.116750_bb0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ki.2010.461","article-title":"Treatment with pyrophosphate inhibits uremic vascular calcification","volume":"79","author":"O'Neill","year":"2011","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.bone.2023.116750_bb0130","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ajpath.2017.02.009","article-title":"Pyrophosphate supplementation prevents chronic and acute calcification in ABCC6-deficient mice","volume":"187","author":"Pomozi","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.bone.2023.116750_bb0135","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1080\/15384101.2015.1007809","article-title":"The effects of bisphosphonates on ectopic soft tissue mineralization caused by mutations in the ABCC6 gene","volume":"14","author":"Li","year":"2015","journal-title":"Cell Cycle"},{"issue":"4","key":"10.1016\/j.bone.2023.116750_bb0140","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/exd.14498","article-title":"Oral supplementation of inorganic pyrophosphate in pseudoxanthoma elasticum","volume":"31","author":"Kozak","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.bone.2023.116750_bb0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ki.2008.646","article-title":"Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure","volume":"75","author":"Lomashvili","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.bone.2023.116750_bb0150","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1038\/ncomms10006","article-title":"ENPP1-fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy","volume":"6","author":"Albright","year":"2015","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bone.2023.116750_bb0155","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035691","article-title":"ENPP1 enzyme replacement therapy improves blood pressure and cardiovascular function in a mouse model of generalized arterial calcification of infancy","volume":"11","author":"Khan","year":"2018","journal-title":"Dis. Model. Mech."},{"issue":"8","key":"10.1016\/j.bone.2023.116750_bb0160","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/jbmr.4315","article-title":"INZ-701 prevents ectopic tissue calcification and restores bone architecture and growth in ENPP1-deficient mice","volume":"36","author":"Cheng","year":"2021","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2023.116750_bb0165","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/exd.14587","article-title":"INZ-701, a recombinant ENPP1 enzyme, prevents ectopic calcification in an Abcc6(-\/-) mouse model of pseudoxanthoma elasticum","volume":"31","author":"Jacobs","year":"2022","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bone.2023.116750_bb0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2023.116750_bb0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI106589","article-title":"Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone","volume":"50","author":"Russell","year":"1971","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bone.2023.116750_bb0180","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0003-2697(74)90407-2","article-title":"Measurement of inorganic pyrophosphate in biological fluids and bone tissues","volume":"61","author":"Cartier","year":"1974","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.bone.2023.116750_bb0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0009-8981(76)90061-9","article-title":"A rapid, enzymatic assay for measurement of inorganic pyrophosphate in biological samples","volume":"66","author":"Lust","year":"1976","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.bone.2023.116750_bb0190","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/art.1780220812","article-title":"Quantification of human plasma inorganic pyrophosphate. I. Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease","volume":"22","author":"Ryan","year":"1979","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.bone.2023.116750_bb0195","first-page":"365","article-title":"Variation in plasma and urinary inorganic phosphate and pyrophosphate in normal subjects and in patients with acromegaly or osteoarthritis","volume":"7","author":"Camerlain","year":"1980","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.bone.2023.116750_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/clinem\/dgab615","article-title":"A reference range for plasma levels of inorganic pyrophosphate in children using the ATP sulfurylase method","volume":"107","author":"Bernhard","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.bone.2023.116750_bb0205","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/ATVBAHA.114.304017","article-title":"ABCC6-mediated ATP secretion by the liver is the main source of the mineralization inhibitor inorganic pyrophosphate in the systemic circulation-brief report","volume":"34","author":"Jansen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.bone.2023.116750_bb0210","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.str.2012.09.001","article-title":"Structure of NPP1, an ectonucleotide pyrophosphatase\/phosphodiesterase involved in tissue calcification","volume":"20","author":"Jansen","year":"2012","journal-title":"Structure"},{"issue":"2","key":"10.1016\/j.bone.2023.116750_bb0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00223-022-00965-1","article-title":"A systematic review of the circadian rhythm of bone markers in blood","volume":"112","author":"Diemar","year":"2022","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bone.2023.116750_bb0220","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s002239900256","article-title":"Diurnal variation of bone mineral turnover in elderly men and women","volume":"60","author":"Greenspan","year":"1997","journal-title":"Calcif. Tissue Int."},{"issue":"8","key":"10.1016\/j.bone.2023.116750_bb0225","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.1780220813","article-title":"Quantification of human plasma inorganic pyrophosphate. II. Biologic variables","volume":"22","author":"Ryan","year":"1979","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.bone.2023.116750_bb0230","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1172\/JCI107369","article-title":"Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia","volume":"52","author":"Silcox","year":"1973","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.bone.2023.116750_bb0235","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jbmr.2178","article-title":"Clinical and radiographic findings in adults with persistent hypophosphatasemia","volume":"29","author":"McKiernan","year":"2014","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328223000832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:04:56Z","timestamp":1757613896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328223000832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":47,"alternative-id":["S8756328223000832"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2023.116750","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of food, fasting, and exercise on plasma pyrophosphate levels and ENPP1 activity in healthy adults","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2023.116750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116750"}}